Concepedia
Statistics
Publications
10
Citations
431
H-Index
Active since
2014
Affiliations
Novo Nordisk (Denmark)(Current)
Brod Group
Novo Nordisk (United States)
Annie Nikolajsen is an author at Novo Nordisk (Denmark).
Publications per year
2014–2017
Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin
Kamlesh Khunti, Annie Nikolajsen, Brian Larsen Thorsted et al. · Diabetes Obesity and Metabolism · 2016 · 248 citations · Full text
Timing of Insulin Injections, Adherence, and Glycemic Control in a Multinational Sample of People with Type 2 Diabetes: A Cross-Sectional Analysis
Nicolaas C. Schaper, Annie Nikolajsen, Anna Sandberg et al. · Diabetes Therapy · 2017 · 28 citations · Full text
An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes
Vishal Gupta, Ranya Baabbad, E. Hammerby et al. · Journal of Medical Economics · 2014 · 24 citations
An analysis of the cost-effectiveness of starting insulin detemir in insulin-naïve people with type 2 diabetes
Philip Home, Sei Hyun Baik, Guillermo González-Gálvez et al. · Journal of Medical Economics · 2014 · 23 citations · Full text
The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries
Meryl Brod, Annie Nikolajsen, James Weatherall et al. · Diabetes Therapy · 2016 · 23 citations · Full text
1–5 of 10